Rensheng Wang
Guangxi Medical University(CN)First Affiliated Hospital of GuangXi Medical University(CN)
Publications by Year
Research Areas
Head and Neck Cancer Studies, RNA modifications and cancer, Cancer-related molecular mechanisms research, Lung Cancer Research Studies, MicroRNA in disease regulation
Most-Cited Works
- → Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial(2016)520 cited
- → The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma(2021)381 cited
- → Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Treatment outcomes of a prospective, multicentric clinical study(2014)138 cited
- → Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study(2021)99 cited
- → Identification of miPEP133 as a novel tumor-suppressor microprotein encoded by miR-34a pri-miRNA(2020)96 cited
- → m6A demethylase FTO renders radioresistance of nasopharyngeal carcinoma via promoting OTUB1-mediated anti-ferroptosis(2022)92 cited